Dr. Michael H. Tomasson, MD

Dr. Tomasson practices at University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa.

Dr. Tomasson's NPI, 1841216157, was assigned on July 14, 2006. Dr. Tomasson graduated from Stanford University School of Medicine in 1992. Dr. Tomasson holds Iowa license MD-43803.

Dr. Tomasson's primary practice is University of Iowa Health Care Medical Center, at 200 Hawkins Drive, Iowa City, IA 52242 in Johnson County. The practice phone is (319) 356-1616.

Dr. Tomasson's primary practice is University of Iowa Health Care Medical Center in Iowa City, Iowa, part of The University of Iowa. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Tomasson to 1 more medical group, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Tomasson practices. Vendor and product names are available with a free account.

Internal medicine is Dr. Tomasson's primary specialty in the NPI Registry, under taxonomy code 207RH0000X. The record also lists hematology. Dr. Tomasson is licensed in Iowa.

CMS data shows 35 Medicare services from Dr. Tomasson across 1 procedure code in 2024, all of them office visits, for 24 Medicare patients. Medicare paid $2,011 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 24 Medicare patients who saw Dr. Tomasson in 2024. The largest group is 75 to 84, with 11 patients. 75% of them have high blood pressure, and 58% have high cholesterol. Their average risk score is 2.85, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Tomasson's median patient age at 78, with 50% women.

In 2024, Dr. Tomasson wrote 69 Medicare Part D claims. 84% of them were for generic drugs. CMS names the drug for 28 of them, across 1 drug with 11 or more claims each, at $369 in total drug cost. In 2023, CMS named 77 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 80 out of 100 for Dr. Tomasson for performance year 2024, reported as part of a group. Dr. Tomasson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 50 papers to Dr. Tomasson, published from 2010 to 2024. 2015 was the busiest year, with 6. The most frequent topics are Multiple Myeloma, Leukemia, Myeloid, Acute and Disease Progression. Dr. Tomasson has published most often in N Engl J Med. Dr. Tomasson's most frequent co-authors are John F. Dipersio, MD, Timothy J. Ley, MD and Daniel C. Link, MD.

Dmand AI links Dr. Tomasson to 10 clinical trials, 4 of them phase 2 studies. 5 are still active or recruiting. Conditions studied include Leukemia, Myeloid, Acute, Leukemia, Myeloid and Multiple Myeloma. Washington University School of Medicine sponsors the most, 8.

CMS Open Payments shows 7 general payments to Dr. Tomasson from 3 drug and device companies from 2017 to 2025. Consulting fees make up the largest share, 100% of the total. Janssen Research & Development, LLC paid the most, $51,005. It also lists 31 research payments totaling $23,590 from 2021 to 2024.

Dr. Tomasson graduated from Stanford University School of Medicine in 1992.